165 related articles for article (PubMed ID: 8394726)
61. Treatment of pediatric and adolescent migraine.
Hershey AD; Kabbouche MA; Powers SW
Pediatr Ann; 2010 Jul; 39(7):416-23. PubMed ID: 20666347
[No Abstract] [Full Text] [Related]
62. Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.
Kindt S; Tack J
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():32-9. PubMed ID: 17620086
[TBL] [Abstract][Full Text] [Related]
63. 5-HT1F receptor agonists in acute migraine treatment: a hypothesis.
Ramadan NM; Skljarevski V; Phebus LA; Johnson KW
Cephalalgia; 2003 Oct; 23(8):776-85. PubMed ID: 14510923
[TBL] [Abstract][Full Text] [Related]
64. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
[TBL] [Abstract][Full Text] [Related]
65. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat.
Gobert A; Rivet JM; Lejeune F; Newman-Tancredi A; Adhumeau-Auclair A; Nicolas JP; Cistarelli L; Melon C; Millan MJ
Synapse; 2000 Jun; 36(3):205-21. PubMed ID: 10819900
[TBL] [Abstract][Full Text] [Related]
66. Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol.
Alexander BS; Wood MD
J Pharm Pharmacol; 1987 Aug; 39(8):664-6. PubMed ID: 2888864
[TBL] [Abstract][Full Text] [Related]
67. Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan.
Martelletti P; Stirparo G; Rinaldi C; Giacovazzo M
Int J Clin Pharmacol Res; 1994; 14(5-6):165-75. PubMed ID: 7672873
[TBL] [Abstract][Full Text] [Related]
68. Increased serotonin transporter availability in the brainstem of migraineurs.
Schuh-Hofer S; Richter M; Geworski L; Villringer A; Israel H; Wenzel R; Munz DL; Arnold G
J Neurol; 2007 Jun; 254(6):789-96. PubMed ID: 17351723
[TBL] [Abstract][Full Text] [Related]
69. [Role of serotonin and its receptors in the pathogenesis of arterial hypertension].
Belousov IuB; Krivonkin KIu
Kardiologiia; 1992; 32(11-12):5-9. PubMed ID: 1297881
[No Abstract] [Full Text] [Related]
70. 5-HT1A receptors and 5-HT1A-mediated responses: effect of treatments that modify serotonergic neurotransmission.
Frazer A; Hensler JG
Ann N Y Acad Sci; 1990; 600():460-74; discussion 474-5. PubMed ID: 2174665
[No Abstract] [Full Text] [Related]
71. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
Dlohozková N; Metys J; Valchár M; Soucek R
Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
[No Abstract] [Full Text] [Related]
72. Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission.
Berggren U; Eriksson M; Fahlke C; Balldin J
Drug Alcohol Depend; 2002 Jan; 65(2):159-65. PubMed ID: 11772477
[TBL] [Abstract][Full Text] [Related]
73. Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain.
Kilinc E; Guerrero-Toro C; Zakharov A; Vitale C; Gubert-Olive M; Koroleva K; Timonina A; Luz LL; Shelukhina I; Giniatullina R; Tore F; Safronov BV; Giniatullin R
Neuropharmacology; 2017 Apr; 116():160-173. PubMed ID: 28025094
[TBL] [Abstract][Full Text] [Related]
74. In vitro interactions of serotonin (5-HT) with mononuclear cells from migraine patients: alterations related to the phase of the attack.
Martelletti P; Alteri E; Pesce A; Rinaldi-Garaci C; Giacovazzo M
J Neuroimmunol; 1988 Apr; 18(1):17-24. PubMed ID: 3346368
[TBL] [Abstract][Full Text] [Related]
75. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour.
Olivier B; van Oorschot R; Waldinger MD
Int Clin Psychopharmacol; 1998 Jul; 13 Suppl 6():S9-14. PubMed ID: 9728669
[TBL] [Abstract][Full Text] [Related]
76. Serotonergic mechanisms and the new antidepressants.
Stahl SM
Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
[No Abstract] [Full Text] [Related]
77. Serotonin and its receptors in the human CNS with new findings - a mini review.
Hung AS; Tsui TY; Lam JC; Wai MS; Chan WM; Yew DT
Curr Med Chem; 2011; 18(34):5281-8. PubMed ID: 22087825
[TBL] [Abstract][Full Text] [Related]
78. The Journey of the Non-Vascular Relief for Migraine: From 'Triptans' To 'Ditans'.
Xavier AS; Lakshmanan M; Gunaseelan V
Curr Clin Pharmacol; 2017; 12(1):36-40. PubMed ID: 28425871
[TBL] [Abstract][Full Text] [Related]
79. Functional bases for a central serotonergic involvement in classic migraine: a speculative view.
MacKenzie ET; Edvinsson L; Scatton B
Cephalalgia; 1985 Jun; 5(2):69-78. PubMed ID: 3893731
[TBL] [Abstract][Full Text] [Related]
80. Serotonin receptors and therapeutics.
Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
